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ABSTRACT African trypanosomes utilize glycosylphosphatidylinositol (GPI)-anchored
variant surface glycoprotein (VSG) to evade the host immune system. VSG turnover is
thought to be mediated via cleavage of the GPI anchor by endogenous GPI-specific phos-
pholipase C (GPI-PLC). However, GPI-PLC is topologically sequestered from VSG substrates in
intact cells. Recently, A. J. Szempruch, S. E. Sykes, R. Kieft, L. Dennison, et al. (Cell 164:246–
257, 2016, https://doi.org/10.1016/j.cell.2015.11.051) demonstrated the release of nanotubes
that septate to form free VSG1 extracellular vesicles (EVs). Here, we evaluated the rela-
tive contributions of GPI hydrolysis and EV formation to VSG turnover in wild-type
(WT) and GPI-PLC null cells. The turnover rate of VSG was consistent with prior meas-
urements (half-life [t1/2] of ;26h) but dropped significantly in the absence of GPI-PLC
(t1/2 of ;36h). Ectopic complementation restored normal turnover rates, confirming
the role of GPI-PLC in turnover. However, physical characterization of shed VSG in WT
cells indicated that at least 50% is released directly from cell membranes with intact GPI
anchors. Shedding of EVs plays an insignificant role in total VSG turnover in both WT and
null cells. In additional studies, GPI-PLC was found to have no role in biosynthetic and
endocytic trafficking to the lysosome but did influence the rate of receptor-mediated endo-
cytosis. These results indicate that VSG turnover is a bimodal process involving both direct
shedding and GPI hydrolysis.
IMPORTANCE African trypanosomes, the protozoan agent of human African trypa-
nosomaisis, avoid the host immune system by switching expression of the vari-
ant surface glycoprotein (VSG). VSG is a long-lived protein that has long been
thought to be turned over by hydrolysis of its glycolipid membrane anchor.
Recent work demonstrating the shedding of VSG-containing extracellular vesicles
has led us to reinvestigate the mode of VSG turnover. We found that VSG is shed in
part by glycolipid hydrolysis but also in approximately equal part by direct shedding
of protein with intact lipid anchors. Shedding of exocytic vesicles made a very minor
contribution to overall VSG turnover. These results indicate that VSG turnover is a bimodal
process and significantly alter our understanding of the “life cycle” of this critical virulence
factor.
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The parasitic protozoan Trypanosoma brucei (sp.) is endemic to sub-Saharan Africa,where it causes veterinary and human African trypanosomiasis. It has a digenetic
life cycle that alternates between the tsetse fly vector (Glossina) and the mammalian
host. The infectious metacyclic parasite is transmitted by bite to the mammalian host,
where it replicates in the circulation and disseminates to skin and adipose tissue, ulti-
mately invading the central nervous system (1–3). Each bloodstream form (BSF) cell is
coated with a monolayer of a single variant surface glycoprotein (VSG), 10 million cop-
ies per cell, which shields underlying invariant membrane proteins from host immune
responses. Trypanosomes avoid acquired immunity directed at VSG by a process of an-
tigenic variation, where VSGs present on the cell surface are replaced with a newly
transcribed VSG, thereby presenting a new antigen to the immune response (4, 5).
There are up to 2,000 VSG genes per genome, and transcription is from 15 to 20 telo-
meric expression sites (ESs), only one of which is active at a time, thereby ensuring
monoallelic exclusion. Antigenic variation occurs either by activating a new expression
site with a different VSG gene or by gene conversion of the VSG in the active ES with a
new gene from the genomic repertoire.
VSG comprises .90% of the cell surface proteome and is expressed at a high rate
(;30,000 molecules/min), producing enough homodimeric proteins for a new surface
coat every 6-h cell cycle (5). Newly translated VSG is efficiently modified in the endoplas-
mic reticulum (ER) with glycosylphosphatidylinositol (GPI) anchors (6, 7) and then rapidly
transported to the cell surface (half-life [t1/2] of;15 min) (8). The protein remains attached
to the cell surface by its GPI anchor, two per homodimer. In normally replicating trypano-
somes, VSG protein is very stable, with loss from the cell requiring multiple cell cycles (t1/2 of
;30h) (9, 10).
BSF cells have a GPI-specific phospholipase C (GPI-PLC) that is particularly enig-
matic. Approximately 30,000 GPI-PLC molecules are associated with the cytoplasmic
face of intracellular membranes (11–14), though the protein contains no clear N-termi-
nal signal peptide or transmembrane domain. GPI-PLC is tightly regulated, possibly by
dynamic acylation (15, 16), but when cells are disrupted by mechanical or hypotonic
lysis, GPI-PLC gains full access to the cell surface and rapidly cleaves all the VSG GPI
anchors (17, 18). Hydrolysis removes dimyristoylglycerol, releasing soluble VSG (sVSG)
with the glycan portion of the GPI structure still attached to the C terminus. This moi-
ety, the cross-reacting determinant (CRD), can be recognized by specific antibodies
(19) and is diagnostic for GPI hydrolysis.
GPI-PLC’s major function is thought to be normal VSG turnover by regulated hydrolysis
of cell surface GPI anchors, leading to its slow loss from the cell surface and accounting for
normal turnover (9). However, its cytosolic membrane disposition presents a topological par-
adox, as VSG is located on the extracellular side of the plasma membrane of intact cells. GPI-
PLC also reportedly stimulates the endocytosis of another VSG-related single-GPI-anchored
protein, the transferrin receptor (TfR) (20). Other proposed functions for GPI-PLC include me-
tabolism (21, 22), regulated release of VSG during differentiation to the procyclic insect stage
(PCF) (23), and cleavage of misfolded GPI-anchored proteins prior to disposal by ER-associ-
ated degradation (ERAD) (24).
Extracellular vesicles (EVs) are produced by nearly every eukaryotic cell type and are
vital for the pathogenesis of many disease-causing agents (25–27). They play roles in
mediating cellular communication, altering immune reactions, influencing host gene
expression, and spreading virulence factors and drug resistance markers between
pathogens. EVs were recently described in T. brucei as extended nanotubes that bud
from the membrane and septate to form free EVs of ;80 nm (28). These EVs can inter-
act with both host and pathogen by direct membrane fusion, receptor-mediated endo-
cytosis, and receptor-mediated signal transduction. They are both VSG positive (VSG1)
and GPI-PLC1, but it is not known to what extent they contribute to normal turnover
of VSG. In this work, we investigated the relative contributions of GPI hydrolysis and EV
shedding to total VSG turnover. Our results indicate that VSG-containing EVs make a
very minor contribution to this process. Rather, molecular VSG is shed directly from the
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cell surface by GPI hydrolysis and, unexpectedly, by direct dissociation of VSG with fully
intact GPI anchors.
RESULTS
Creation of a GPI-PLC null cell line. A cell line with a puromycin resistance cassette
replacing a single GPI-PLC gene allele was created (GPI-PLC1/2). However, despite multiple
subsequent attempts, we were unable to create a double knockout with a matched
hygromycin resistance cassette. To circumvent this, we introduced a conditional GPI-PLC
gene expression construct into the GPI-PLC1/2 cell line under phleomycin selection and
then targeted the second allele while inducing expression with tetracycline. This approach
worked, but phleomycin was omitted from the clonal selection and, unexpectedly, the re-
sultant clones had lost the inducible copy of the gene, as confirmed by PCR (Fig. 1A) (wild
type [WT] versus 1/2 versus 2/2). This “true” GPI-PLC2/2 null cell line retained puromy-
cin and hygromycin resistance but was now phleomycin sensitive. Interestingly, loss of the
inducible construct is similar to what occurred during the creation of the widely used GPI-
PLC null cell line, RUMP528 (29). Nevertheless, because of the “arcane” derivation of the
null cell line, we confirmed the discrete loss of both alleles by whole-genome sequencing
(see Fig. S1 in the supplemental material).
Null cells completely lack GPI-PLC protein (Fig. 1B) and mRNA (Fig. 1C). Furthermore,
growth of null parasites was unchanged from that of the wild type (WT) (Fig. 1D), confirm-
ing results previously seen with RUMP528. To confirm the loss of GPI-PLC activity in our
null cells, we utilized the hypotonic release assay (18). WT and null cells were subjected to
GPI-PLC-activating hypotonic lysis to allow cleavage of GPI anchors, thereby releasing solu-
ble VSG from the cell surface. Crude membrane and supernatant fractions were then im-
munoblotted with anti-VSG antibody. WT cells showed normal GPI hydrolysis and release
of surface VSG into the supernatant (Fig. 1E, lanes 1 and 2); the small remaining signal in
the membrane fraction represents VSG located in intracellular (secretory and endocytic)
compartments that is inaccessible to GPI-PLC during hypotonic lysis. Null cells, however,
FIG 1 GPI-PLC gene knockout. (A) GPI-PLC wild type (1/1), single knockout (KO) (1/2) and double
KO (2/2) cell lines were genotyped by PCR using specific primers for the GPI-PLC and tubulin gene
open reading frames (ORFs). (B) GPI-PLC protein levels were detected by immunoblotting using anti-
GPI-PLC (G) and anti-VSG (V; load control) antibodies. (C) qRT-PCR of WT, Null, cKO2 (Tet2), and cKO1
(Tet1) cell lines. Values are normalized to WT as fold change (means 6 standard deviations [SDs],
n=3). (D) Growth curves of WT and GPI-PLC null cells, (means 6 SDs, n= 3). Cells were seeded at
5 104/ml and readjusted to starting density every 24 h. (E) Hypotonic lysates were prepared to
activate endogenous GPI-PLC. Membrane (M) and supernatant (S) fractions were prepared and
analyzed by immunoblotting using anti-VSG (V; endogenous GPI-PLC substrate) and anti-BIP (B; load
control) antibodies (2 106 cell equivalents per lane).
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completely lacked GPI-PLC activity, as essentially all VSG remained membrane-associated,
as did the control ER marker protein, BiP (Fig. 1E, lanes 3 and 4). To confirm that the lack
of release was due to loss of GPI-PLC, we reintroduced the inducible copy of the GPI-PLC
gene into the null cells, generating a conditional knockout (cKO) cell line. Quantitative
reverse transcription-PCR (qRT-PCR) analysis indicated tetracycline-responsive expression
of GPI-PLC, albeit at much lower levels than in wild-type cells (Fig. 1C). Nevertheless, this
low level of expression was sufficient to fully restore release of sVSG during hypotonic lysis
(Fig. 1E, compare lanes 5 and 6 versus 7 and 8).
VSG turnover. We next assessed the rate of VSG turnover by pulse-chase radiolab-
eling in wild-type versus null cells. Normal VSG turnover occurred with a half time (t1/2)
of ;26 h (Fig. 2A), which is faster but still consistent with previous reports that were
performed under somewhat different conditions (t1/2 of ;32 h) (9, 10). However, VSG
turnover was slower in null cells (Fig. 2A) (t1/2 of ;36 h), with much less VSG appearing
in the medium over the chase period. Noticeable in both the null cell and medium frac-
tions was the time-dependent appearance of a smaller truncated VSG species that was
absent in the comparable wild-type fractions (Fig. 2A, lanes 2 to 4 and 6 to 8). The rela-
tive size of this species is similar to that of a fragment previously seen during differen-
tiation to the procyclic form of the parasite, which involves endoproteolytic cleavage
and release of VSG by the zinc metalloprotease MSP-B (9, 30). Possibly, the loss of GPI-
PLC leads to dysregulation of this enzyme. To confirm that both phenotypes—delayed
turnover and truncation of VSG—result from GPI-PLC deficiency, we used the inducible
cKO cell line. When GPI-PLC expression was induced (with tetracycline [Tet1]), a turn-
over rate similar to that in wild-type cells was observed (Fig. 2B) (t1/2 of ;21 h versus
26 h), with no appearance of truncated VSG. However, in the absence of GPI-PLC
expression (Tet2) VSG turnover dropped to the same rate as that for bona fide null cells
FIG 2 Turnover of VSG. Wild type versus null (n= 9) (A) and induced (Tet1) versus uninduced (Tet2) cKO (n= 3)
(B) cell lines were analyzed by [35S]Met/Cys pulse-chase radiolabeling, and VSG was immunoprecipitated from
cell and medium fractions at the indicated times. Precipitates were fractionated by SDS-PAGE and quantified by
phosphorimaging (means 6 SDs). Only the 24-h medium time point was quantified, and this is offset in the
graphs for clarity of presentation; the T0 medium time point was subtracted to zero the data. A proteolytic
fragment (star) seen only under GPI-PLC deficiency (null and Tet2 cKO) was included in the quantification for
these experiments. Half-life times (t1/2; determined by linear regression) are indicated. P value was ,0.001 for
each set of GPI-PLC replete versus deficient cell lines.
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(Fig. 2B) (t1/2 of ;36 h versus 34h). Strikingly, truncated VSG was again observed in both cell
and medium fractions (Fig. 2B, bottom, lanes 2 and 3 and lanes 5 and 6). These results indicate
that both phenotypes are due to GPI-PLC deficiency. All attempts to inhibit VSG truncation in
null cells were either unsuccessful (FMK024, a T. brucei cathepsin L [TbCathepsin L] inhibitor) or
inconclusive (specific metalloprotease inhibitors [structures SB227961 and SB227962] found in
reference 31). Overall, these data confirm that VSG turnover occurs by shedding from the cell
surface as originally reported (9, 10), with a basal rate of t1/2 of ;26h, somewhat faster than,
but still similar to, the prior publications. However, GPI-PLC activity is apparently not required
for VSG turnover, although its deficiency does delay shedding (t1/2 of;36h).
VSG shedding. To investigate the mode of VSG shedding, we subjected conditioned me-
dium (CM) from cultures of WT and GPI-PLC2/2 null cell lines to density floatation, followed by
immunoblotting with anti-VSG antibody to identify total protein and anti-CRD antibody to
assess GPI hydrolysis (Fig. 3A). Detergent {16mM 3-[(3-cholamidopropyl)-dimethylammonio]-
1-propanesulfonate (CHAPS)} was included in control flotations to solubilize any VSG that
might be in EVs. In WT cells, most VSG was found in the nonbuoyant fractions (4 and 5), and
this was strongly reactive with the anti-CRD antibody, indicating hydrolyzed GPI anchors. A
small amount of buoyant VSG was detected (fractions 2 and 3), but this was nonreactive with
FIG 3 Characterization of shed VSG. Conditioned culture supernatants (CMs) were generated by incubating freshly harvested late-log-phase cells in fresh
HMI-9 medium (6 h, 107/ml). (A) Wild-type (WT) and GPI-PLC2/2 (null) conditioned culture supernatants (106 cell equivalents) were fractionated by density
floatation (diagram) in the absence and presence of 16mM CHAPS (2 CMC). Gradient fractions were analyzed by immunoblotting with anti-VSG and anti-
CRD antibodies. Vertical white lines indicate sections that were digitally excised for presentation after image processing. Mobility of molecular mass
markers is indicated (right). WT versus null data are from different gels/images, and can only be compared qualitatively. (B) Gel filtration of WT conditioned
medium. CM (0.5ml) was gravity applied to an EV35 column, and 0.5-ml fractions were collected from T0. The A280 of each fraction was determined, and
VSG was assayed by immunoblotting (inset). Note that fractions 10 and 11 were omitted. Each run was normalized to the fraction with the highest value,
and data are presented as means 6 SDs (n= 3). For CHAPS treatment, load samples were adjusted to 16mM CHAPS and run in buffer with 1mM CHAPS.
(C) CM plus (1) or minus (2) 1% dodecylmaltoside (DDM) was fractionated by blue native gel electrophoresis and analyzed by immunoblotting. Purified
sVSG (V; MITat1.2) was run as a control. A darker exposure of the CM lanes is presented on the right. DDM-sensitive high-molecular-weight VSG is
indicated (star). Note that native VSG consistently migrates at approximately twice its known size (;110 kDa) relative to the manufacturer supplied markers.
This effect, which is likely due to the highly elongated and glycosylated nature of VSGs in general, has been noted by others (46). (D) WT and null CMs
were subjected to sequential immunoprecipitation, 3 with anti-CRD (1°, 2°, and 3°) and then twice with anti-VSG (4° and 5°) antibodies. Precipitates were
analyzed by immunoblotting with anti-VSG antibody. Mobilities of full-length (Vf) and truncated (Vt) VSG and background immunoglobulin heavy chain (Ig)
are indicated. Fractional recoveries for each precipitation are shown (bottom).
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the anti-CRD antibody and was reduced by CHAPS treatment, consistent with shed EVs con-
taining VSG with intact GPI anchors. In CM from null cells, the amount of nonbuoyant VSG
(fractions 4 and 5) was greatly reduced relative to that of buoyant VSG (fractions 2 and 3),
and all VSG was CRD negative. (Note that the relative total VSG signals in WT versus null
cells cannot be compared directly, as these are different gels with different phosphori-
mages. For quantitative comparison see Fig. 3C.) Again, buoyant VSG was susceptible to
CHAPS treatment. Interestingly, as seen in pulse-chase analyses (Fig. 2), both full-length and
truncated VSG were found in the nonbuoyant fractions. We interpret this as heterodimeric
VSG in which one subunit has been cleaved toward the C terminus, thereby removing one
GPI anchor. As one BSF GPI anchor (dimyristoylglycerol) is not sufficient to maintain
membrane association (32), these heterodimers are shed into the medium during culture
and do not float during centrifugation. The results of gel filtration and blue native gel elec-
trophoresis support this conclusion (see below).
Three additional physical assessments of shed VSG were performed. First, CM (WT only)
was size selected on qEV35 columns (fractionation range 35 to 350nm) (Fig. 3B, left). The
A280 profile shows a leading peak (fraction number [fr. no.] 17) followed by a main peak
that represents maximum inclusion of free serum proteins (fr. no. 21). Low levels of VSG
were consistently found in the breakthrough fractions (fr. no. 7 and 8), but the overwhelm-
ing amount of VSG was centered on fractions 15 and 16, in advance of both the A280 peaks.
Treatment with CHAPS (Fig. 3B, right) had minimal effect on elution of the main VSG peak
but completely eliminated the small breakthrough VSG peak, suggesting this represents
EVs equivalent to the buoyant material in floatation assays. Proteomic analysis of the main
peak only detected VSG protein, and no other T. brucei proteins were detected (data not
shown). Gel filtration of purified sVSG (;110 kDa) indicated that it elutes identically to the
main VSG peak in CM (see Fig. S2, fr. no. 16). Second, WT and Null CMs were fractionated
by blue native gel (BNG) electrophoresis (Fig. 3C). In each case, VSG in CM overwhelming
comigrated with the purified homodimeric sVSG control and was unaffected by addition
of detergent. As expected, the overall signal was reduced in null CM relative to that from
the WT. However, with overexposure, a small amount of detergent-sensitive high-molecu-
lar-weight VSG was detected, again consistent with the presence of a small amount of VSG
in shed EVs. This material was somewhat more abundant in null cells, suggesting that the
loss of GPI-PLC might influence EV production (see below). Finally, CM was subjected to
sequential immunoprecipitation with anti-CRD and anti-VSG antibodies (Fig. 3D). Three
rounds of treatment with anti-CRD antibodies were sufficient to deplete VSG with hydro-
lyzed GPI anchors from WT CM. Two additional rounds of treatment with anti-VSG antibod-
ies precipitated the remaining VSG with intact GPI anchors, which represents approxi-
mately half of all VSG shed from intact cells (47.1%6 14.0%, n=3). As expected, no VSG
was detected in null CM with the anti-CRD antibody, indicating that all shed VSG had intact
GPI anchors. Collectively, these results indicate that most VSG is shed from WT cells as intact
homodimers, which are quite evenly split between hydrolyzed and intact GPI anchors. The
latter population accounts for all VSG turnover in GPI-PLC2/2 cells.
EV formation. Our physical characterization of shed VSG indicates that most VSG is
released directly from the cell surface in WT cells. However, small amounts of VSG are
shed in EVs, and this makes a minor contribution to VSG turnover in WT and null cells.
To assess whether loss of GPI-PLC affects EV production, we performed scanning electron
microscopy (SEM) to quantify cell-associated nanotubes, which are the precursors of free
EVs (28). Both WT and null cells had the rugose surface topology typically seen at low
voltages (33) (Fig. 4 A). Cells bearing nanotubes (;10%) (Fig. 4B) were quantified for
number, length, and diameter (Fig. 4C to E). The only noticeable difference in nanotube
production was a small but statistically significant increase in the diameter in null cells
(132.66 34.0nm versus 108.06 30.1 nm, P = 0.013). To further investigate this phenom-
enon, EVs were purified from conditioned medium from cultures of WT and GPI-PLC2/2
cells (28) and analyzed by nanoparticle tracking. EVs from null cells were more abundant
(Fig. 4F), consistent with the increased high-molecular-weight and detergent-sensitive
material seen in BNG analysis. EVs from null cells were also larger in mean diameter
Garrison et al. ®












































(138.06 2.6 nm versus 127.76 1.5 nm, n=3, P , 0.005), matching the increased diame-
ter of cell-associated nanotubes. Unfractionated EVs in CM were confirmed to be VSG
containing, and hence trypanosome derived, by immunofluorescent ImageStream analy-
sis (see Fig. S3). These results indicate that shedding of VSG in EVs, although still a very
minor component of total shed VSG, is increased in the absence of GPI-PLC.
DISCUSSION
It has long been thought that normal VSG turnover occurs by GPI-PLC-mediated hy-
drolysis of the GPI anchor, leading to slow release of soluble CRD1 VSG into the extrac-
ellular milieu (9). However, there is a topological problem with this model, as the cyto-
solically disposed GPI-PLC is sequestered from cell surface VSG in intact cells. GPI-PLC
can cleave surface VSG when cells are disrupted by hypotonic or mechanical lysis (17,
18), but such unrestricted access would be catastrophic in intact cells. Nevertheless,
FIG 4 Formation of membrane nanotubes. Wild-type (WT) and GPI-PLC2/2 (null) cells were fixed, captured on 0.2-mm filters, and processed
for SEM. (A) Representative SEM images of WT and null cells and cells with budding nanotubes. Nanotubes in WT and null cells were
quantified for frequency (B), number per cell (C), length (D), and diameter (E) (n= 3, 100 cells per biological replicate). The statistical
significance of WT versus null diameter is indicated. (F) Nanoparticle tracking analysis. Representative analyses of number (left) and average
size (right) of particles recovered by ultracentrifugation from WT and null conditioned medium (median signal from 10 technical replicates).
Inset graphs show quantification of each (mean 6 SD, n= 3 biological replicates).
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GPI-PLC is found on the surface of differentiated, short stumpy bloodstream forms and
actively releases VSG as a prelude to further differentiation when taken up by the
tsetse (23). Thus, a model of slow regulated release by GPI hydrolysis cannot be
excluded for normal VSG turnover in replicating BSF parasites. However, GPI-PLC null
BSF cells are fully viable and able to differentiate into PCF with normal kinetics (34, 35),
a process that requires replacement of the VSG surface coat with a new coat made of
procyclins. In addition, null cells can also undergo VSG switching, indicating that GPI-
PLC is not essential for antigenic variation (35). Thus, GPI-PLC activity is not required
for other known processes involving turnover of VSG.
These issues, along with recent work demonstrating that bloodstream trypano-
somes actively release EVs containing VSG (28), have led us to reinvestigate the relative
extents to which GPI hydrolysis and EV formation contribute to VSG turnover. VSG is
consistently lost from cells into the medium with a half-life of ;26 h in WT cells, in
good agreement with previous reports (9, 10). Furthermore, GPI-PLC null cells have sig-
nificantly slower VSG turnover (t1/2 of ;36 h), consistent with the hydrolysis model (9).
Nevertheless, shedding continues in the null cells, albeit at reduced rate, formally prov-
ing that GPI-PLC is not required for normal VSG turnover. However, very little of this
VSG is shed in a form that is consistent with inclusion in membranous EVs, i.e., suscep-
tible to detergent treatment in floatation, gel filtration, or BNG analyses. Rather, it is
shed directly from the cell surface as VSG homodimers with intact (CRD2) GPI anchors.
The situation is more complicated in WT cells, where VSG is shed in approximately
equal portions as GPI-intact and GPI-hydrolyzed (CRD1) forms. This finding indicates
that normal VSG turnover is a bimodal process involving both direct dissociation from
the cell surface and release by GPI hydrolysis. The latter accounts for the elevated rate
of release from WT cells compared to that from the null cells. It is also likely that a
hybrid process occurs in which one GPI anchor is hydrolyzed and the protein then dis-
sociates with a single GPI anchor. In either case, the amount of VSG shed in detergent-
sensitive EVs is a very small portion of the total, although loss of GPI-PLC does increase
the size and abundance of these particles. Phosphatidylinositides are known to be GPI-
PLC substrates (21, 22), and, presumably, this size effect is mediated by the disruption
of phosphoinositide and/or diacylglycerol signaling pathways, as suggested in refer-
ence 20. The only other phenotype of GPI-PLC knockout is the appearance of a VSG
fragment in both cell and medium fractions of GPI-PLC-deficient cells, which is reminis-
cent of the proteolytic cleavage that takes place during differentiation to procyclics
(23). This may represent dysregulation of the metalloprotease MSP-B that is upregu-
lated for VSG release during differentiation (30). Whatever the explanation, the pheno-
type is a real consequence of GPI-PLC deficiency, as the addback completely eliminates
generation of the fragment.
Our findings raise two issues. First is the GPI-PLC topology problem: the enzyme is
on the cytoplasmic side, while the substrate is on the extracellular side. As mentioned
above, active GPI-PLC is present on the surface of differentiated short stumpy parasites,
but a priori, this seems risky in replicating long slender BSF parasites, where mainte-
nance of an intact surface coat is paramount for survival. Consequently, we were ini-
tially doubtful about the original demonstration of VSG turnover by GPI hydrolysis (9).
This concern was compounded by the two criteria used to evaluate the GPI status of
released VSG. First, released material was judged to be hydrolyzed sVSG on the basis of
electrophoretic mobility, but the difference in mobility between the two forms is
subtle, requiring special electrophoretic methods such as urea or gradient gels to visu-
alize (6, 17). Second, released VSG was found to be CRD1 by immunoblotting, but the
relative amount of conversion was not assessed. Thus, it was possible that low-level
GPI hydrolysis occurred but was mistaken for quantitative shedding of soluble VSG.
However, our results demonstrate that GPI hydrolysis does account for approximately
half of all VSG turnover. That said, it is likely this is an overestimate, as even a very low
level of cell death during culture, which is impossible to avoid, would lead to GPI-PLC
activation and VSG release. How GPI-PLC “translocates” to the cell surface, in either
Garrison et al. ®












































long slender or short stumpy parasites, is not clear. However, GPI-PLC is reversibly thio-
acylated (16), and it was suggested that this regulates access to cell surface VSG in
intact cells (16, 23). Whatever the mechanism of translocation, it must be tightly regu-
lated, as too much active surface GPI-PLC would likely be lethal.
The second issue is shedding of homodimeric VSG with two intact GPI anchors. This
can only be by direct dissociation from the intact plasma membrane. We previously
demonstrated that a single BSF GPI anchor is not sufficient to maintain membrane
association (32). This is because the BSF GPI is composed exclusively of dimyristoylgly-
cerol (36), which has a high off rate (t1/2 of ;14min) from biological membranes at 37°C
(37, 38) and which is accentuated by attachment of bulky molecules, e.g., proteins.
Furthermore, it has been observed that VSG can spontaneously transfer from live BSF try-
panosomes into the membranes of nearby erythrocytes (39), a process that may contrib-
ute to the anemia associated with prolonged trypanosome infection. Apparently then, two
dimyristoylglycerol GPI anchors are also insufficient to maintain membrane association,
albeit with a much lower off rate.
These data along with those from previous studies on GPI-PLC function establish
five principal functions for this enigmatic enzyme. First is normal turnover of VSG by
GPI hydrolysis, in concert with direct shedding of intact VSG, in replicating BSF cells.
Second, in partner with the metalloprotease MSP-B, is release of VSG from the cell sur-
face during differentiation from short stumpy BSF to PCF stages. As noted above, GPI-
PLC is present on the surface of short stumpy BSF parasites already releasing VSG prior
to ingestion by the tsetse (23, 30). Release of soluble VSG into circulation by both replicating
and short stumpy trypanosomes is likely to have significant effects on host innate immune
responses (40). Third, GPI-PLC plays a poorly understood role in regulating receptor-medi-
ated endocytosis (20). Fourth, GPI-PLC may be a metabolic enzyme. Although commonly
thought to be GPI specific, it is fully active against PI (21). Furthermore, silencing in BSF cells
show reduced incorporation of myo-inositol into inositol polyphosphates (22), suggesting
that GPI-PLC cleaves higher-order phosphoinositides. Finally, during ER-associated degrada-
tion (ERAD) in BSF trypanosomes, misfolded GPI-anchored proteins are retrotranslocated
from the ER lumen to the cytosolic side of the ER membrane, where they must be extracted
before proteasomal degradation in the cytoplasm. We have shown that GPI hydrolysis pre-
cedes extraction and degradation, and the cytoplasmic disposition of GPI-PLC makes it the
obvious candidate for this function (24).
In summary, we have reevaluated normal VSG turnover in actively dividing popula-
tions of BSF trypanosomes. As long thought, GPI hydrolysis is an important part of this
process. However, direct shedding of VSG with intact GPI anchors may be the major
mechanism and, in the absence of GPI-PLC, is capable of maintaining VSG turnover. In
contrast, shedding of VSG in membrane-derived EVs plays a minimal role at best in
VSG turnover. Thus, VSG turnover is essentially a bimodal process involving shedding
of intact and GPI-hydrolyzed VSG homodimers.
MATERIALS ANDMETHODS
Cell lines and culture. All work was carried out with cultured log-phase BSF cells of the commonly
used tetracycline-responsive single-marker (SM221) Lister 427 strain of T. brucei brucei (variant antigenic
type MITat1.2 expressing VSG221) (41), grown in HMI-9 medium (42).
Hypotonic lysis assay. Cells were washed with ice cold HEPES-buffered saline (HBS; 50mM HEPES-
KOH [pH 7.5], 5mM KCl, 50mM NaCl, 70mM glucose) and suspended in ice-cold distilled water (dH2O)
(107 cells, 180ml) with protease inhibitor cocktail (PIC; 2mg/ml of leupeptin, antipain, chymostatin, pep-
statin A, and aprotinin) and Na-tosyl-L-lysine chloromethyl ketone hydrochloride (TLCK; 0.37mg/ml).
Samples were kept on ice for 5 min and then supplemented with 20ml of 10 TEN buffer (1: 50mM
Tris-HCl, pH 7.5, 150mM NaCl, 5mM EDTA) and incubated at 37°C for 10 min to activate endogenous
GPI-PLC. Membrane and supernatant fractions were prepared by centrifugation at 4°C. Samples were im-
munoblotted simultaneously with specific anti-VSG and anti-BiP antibodies.
VSG turnover assay. BSF trypanosomes were radiolabeled (15min) with [35S]methionine/cysteine as
described in reference 43 using methionine/cysteine-free TM-B medium (44), washed in HBS, and resus-
pended in prewarmed (37°C) HMI-9 growth medium at 5 104 cells/ml. Incubation was continued for 24h. At
each time point, two consecutive volumes of cells (1ml total) were gently centrifuged (3,000  g, 1min) in
0.45-mm SpinX centrifuge filters (Corning Inc., Salt Lake City, UT). Pass-through medium samples were supple-
mented with one-tenth volume of 10 radioimmunoprecipitation assay (RIPA) detergents (final, 1% NP-40,
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0.5% deoxycholate, 0.1% SDS) and reserved on ice. The filter inserts with cells were transferred to fresh tubes,
and cells were lysed with two consecutive volumes of 1 RIPA buffer (1ml total), again with gentle centrifuga-
tion. All medium and lysate samples were then subjected to standard immunoprecipitation.
Conditioned medium floatation assays. To generate VSG-containing conditioned medium (CM),
washed cells were resuspended at 107/ml in HMI-9 medium and incubated for 6 h at 37°C. Following
incubation, cells were removed on Costar SpinX centrifuge filters (0.45mm; Corning Inc., Salt Lake City,
UT), and the cleared CM was supplemented with protease inhibitor cocktail (PIC; 2mg/ml of leupeptin,
antipain, chymostatin, pepstatin A, and aprotinin). For analytical step floatation gradients, CM was
adjusted to 40% OptiPrep (Sigma-Aldrich, St. Louis, MO), and 350ml was overlaid with 35% OptiPrep
phosphate-buffered saline (PBS) (600ml) and 10% OptiPrep-PBS (450ml) in thick wall polycarbonate TLS-
55 tubes (Beckman Coulter Inc., Brea, CA). After centrifugation (TLS-55 rotor, 200,000  g, 2 h, 4°C), gra-
dients were manually fractionated from the top (5 280-ml fractions). Samples were fractionated by
SDS-PAGE and immunoblotted with anti-VSG221 VSG or anti-CRD antibodies (12).
Size exclusion chromatography. qEVoriginal/35-nm columns (EV35; iZon, Medford, MA) were
washed with PBS and then loaded with CM (0.5ml). The column was eluted with PBS, and 0.5-ml frac-
tions were collected. The A280 for each fraction was measured by NanoDrop spectrophotometry.
Individual fractions were subjected to SDS-PAGE and immunoblotted with an anti-VSG221 antibody. For
detergent treatment, CHAPS was added to load fractions (16mM final; 2 CMC), and the column was
equilibrated and run in PBS with 1mM CHAPS.
Scanning electron microscopy. SEM was performed as described previously, and cells were fixed
and dehydrated as described previously (33). Briefly, late-log-phase cells (0.5 105 to 1.0 105/ml) were
fixed with 2.5% EM-grade glutaraldehyde (Electron Microscopy Sciences) in complete HMI-9 medium
(2 h at 4°C). Cells were then gently collected by syringe-passage onto 0.2-mm-pore polycarbonate filters
(Whatman Nuclepore, 25-mm diameter; Sigma-Aldrich) keeping fluid in the upper filter chamber
(Whatman Swin-Lok cartridge, 25mm; Sigma-Aldrich) in all subsequent steps until final air drying. Cells
were washed and dehydrated through an ethanol series and finally dried with hexamethyldisilazane.
Filters were removed and air dried, and samples were coated with evaporated carbon at high vacuum
(Denton 502 evaporator). Images were acquired on a Hitachi SU70 field emission scanning electron
microscope (FESEM) at 2.0 keV using an in-lens secondary electron detector at zero tilt or a lower detec-
tor at 70° tilt. Nanotubes were quantified from 3 biological replicates of 100 randomly selected cells in
zero-tilt images.
Nanoparticle tracking analysis of EVs. EVs were purified as described in reference 28 from condi-
tioned medium prepared from WT and GPI-PLC null cells. In brief, cells were grown overnight in com-
plete HMI-9 medium with EV-depleted fetal bovine serum (FBS). Cells were removed by centrifugation at
3,000 g for 15 min, followed by an additional spin at 10,000 g for 15 min to remove large debris, and
lastly filtered through a 0.45-mm filter to create conditioned medium. EVs were pelleted by ultracentrifu-
gation in a Ti45 rotor at 120,000  g for 1 h 34 min and washed twice with PBS. The concentration, diam-
eter, and labeling intensity of ultracentrifugation-purified EVs were determined using the NanoSight
NS300 (Malvern Panalytical, Malvern, UK). For each sample, 10 replicate videos were captured for 1 min
each using a 532-nm laser at camera level of 14. Analysis of videos was performed within NanoSight
NTA software 3.2 Dev Build 3.2.16 using the settings of detect threshold 4, auto blur size, and auto max
jump distance.
Imaging flow cytometry. Protein A-purified rabbit VSG221 antibody was conjugated with Alexa
Fluor 555 (Invitrogen, catalog no. A37571) and the degree of labeling was determined to be 1.8 mole-
cules per antibody. Antibody solution was precleared to remove aggregates by spinning at 16,000 g
for 30 min at 4°C. EVs were labeled with 25mg/ml (20ml final volume in PBS) of labeled antibody for 30
min in the dark at room temperature and then diluted 5-fold and placed on ice before being processed.
Imaging flow cytometry acquisition was performed on an ImageStreamX Mk II (Luminex Corporation,
Seattle, WA) with fluidics set at medium speed, sensitivity set to high, magnification set to 60, and laser
power set to high. All samples were acquired using the autosampler with INSPIRE software for an acqui-
sition time of 2 min per sample. Three or four technical replicates were performed for all samples, with a
PBS wash in between each sample type. Gates were set and quantified using IDEAS software version 6.2.
P values shown were acquired from GraphPad Prism v7, with each row analyzed individually and a two-
stage step-up method as described in reference 45.
Data analyses. ImageJ (http://imagej.nih.gov/ij/) was used to quantify data from phosphorimager
assays and fluorescence blot scans. For quantitative analysis of band intensities, signals from each lane
were subtracted from the signal of the equivalent unlabeled areas of that lane. In the case of the VSG
turnover assay, the zero supernatant signal was subtracted from all subsequent supernatant signals.
Data analyses were performed with Prism 6 software (GraphPad Software, Inc., San Diego, CA). Biological
replicates (n) were obtained as indicated in the text.
SUPPLEMENTAL MATERIAL
Supplemental material is available online only.
FIG S1, TIF file, 2.9 MB.
FIG S2, TIF file, 0.1 MB.
FIG S3, TIF file, 1.8 MB.
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